← JOHNSON & JOHNSON
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Net earnings | $15.4b | $16.5b | $15.3b | $15.1b | — | $14.7b | $20.9b | $17.9b | $14.1b | $26.8b | |
| Net Income (Loss) Attributable to Parent | — | $1.3b | $15.3b | $15.1b | $14.7b | $20.9b | — | $35.2b | $14.1b | $26.8b | |
| Cash and cash equivalents from continuing operations, beginning of period | — | — | — | — | — | — | — | $21.9b | $24.1b | $19.7b | |
| Cash and cash equivalents from discontinued operations, beginning of period | — | — | — | — | — | — | — | $0 | $0 | $0 | |
| Income taxes, inclusive of discontinued operations | $2.9b | $2.8b | $4.6b | $4.2b | — | $4.6b | $4.8b | $5.2b | $6.7b | $6.5b | |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | — | — | — | — | — | — | — | — | — | — | |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | — | — | — | — | — | — | — | $13.3b | $14.1b | $26.8b | |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent | — | — | — | — | — | — | — | $21.8b | $0 | $0 | |
| Net Income (Loss) Attributable to Noncontrolling Interest | — | — | — | — | — | — | — | — | — | — | |
| Depreciation, Depletion and Amortization | — | $5.6b | $6.9b | $7.0b | $7.2b | $7.4b | — | $7.5b | $7.3b | $7.5b | |
| Amortization of Intangible Assets | — | $3.0b | $4.4b | $4.5b | $4.7b | $4.7b | — | $4.5b | $4.5b | $4.6b | |
| Depreciation and amortization of property and intangibles | $3.7b | $3.8b | $6.9b | $7.0b | — | $7.2b | $7.4b | $7.0b | $7.3b | $7.5b | |
| Deferred Income Tax Expense (Benefit) | — | $2.4b | ($1.0b) | ($2.5b) | ($1.1b) | ($2.1b) | — | ($4.2b) | ($2.2b) | $1.5b | |
| Deferred tax provision | ($270.0m) | ($341.0m) | ($1.0b) | ($2.5b) | — | ($1.1b) | ($2.1b) | ($1.7b) | ($2.2b) | $1.5b | |
| Share-based Payment Arrangement, Noncash Expense | — | $962.0m | $978.0m | $977.0m | $1.0b | $1.1b | — | $1.2b | $1.2b | $1.4b | |
| Share-based Payment Arrangement, Expense | — | $962.0m | $978.0m | $977.0m | $1.0b | $1.1b | — | $1.1b | $1.2b | $1.4b | |
| Gain (Loss) on Sale of Assets and Asset Impairment Charges | — | $1.3b | $1.2b | $2.2b | $111.0m | $617.0m | — | $117.0m | $226.0m | $263.0m | |
| Gain (Loss) on Disposition of Assets | — | $1.3b | $1.2b | — | — | — | — | — | — | — | |
| Income Tax Expense (Benefit) | — | $16.4b | $2.7b | $2.2b | $1.8b | $1.9b | — | $1.7b | $2.6b | $5.8b | |
| Interest Expense Nonoperating | — | — | — | — | — | — | — | — | $755.0m | $971.0m | |
| Other Nonoperating Income (Expense) | — | ($183.0m) | ($1.4b) | ($2.5b) | ($2.9b) | ($489.0m) | — | ($6.6b) | ($4.7b) | $7.2b | |
| Changes in operating assets and liabilities: | |||||||||||
| Additional Financial Items | |||||||||||
| Increase (Decrease) in Accounts Receivable | — | $633.0m | $1.2b | $289.0m | ($774.0m) | $2.4b | — | $624.0m | $406.0m | $1.8b | |
| Increase (Decrease) in Inventories | — | ($581.0m) | $644.0m | $277.0m | $265.0m | $1.2b | — | $1.3b | $1.1b | $1.4b | |
| Equity Securities, FV-NI, Gain (Loss) | — | — | — | — | — | — | — | ($400.0m) | ($400.0m) | — | |
| Foreign Currency Transaction Gain (Loss), before Tax | — | ($216.0m) | ($265.0m) | ($267.0m) | ($209.0m) | ($236.0m) | — | ($366.0m) | ($214.0m) | ($254.0m) | |
| Gain (Loss) Related to Litigation Settlement | — | — | — | — | — | — | — | $100.0m | — | — | |
| Goodwill | — | $31.9b | $30.5b | $33.6b | $36.4b | $35.2b | — | $36.6b | $44.2b | $48.8b | |
| Investment Income, Interest | — | $385.0m | $611.0m | $357.0m | $111.0m | $53.0m | — | $1.3b | $1.3b | $1.1b | |
| Stock based compensation | $874.0m | $878.0m | $978.0m | $977.0m | — | $1.0b | $1.1b | $1.1b | $1.2b | $1.4b | |
| Asset write-downs | $624.0m | $283.0m | $1.3b | $1.1b | — | $233.0m | $989.0m | $1.2b | $405.0m | $204.0m | |
| Charges for acquired in-process research and development | — | — | — | — | — | — | — | $483.0m | $1.8b | $109.0m | |
| (Gain) on separation of Kenvue | — | — | — | — | — | — | — | ($21.0b) | $0 | $0 | |
| Net gain on sale of assets/businesses | ($2.6b) | ($563.0m) | ($1.2b) | ($2.2b) | — | ($111.0m) | ($617.0m) | ($380.0m) | ($226.0m) | ($263.0m) | |
| Credit losses and accounts receivable allowances | $18.0m | ($11.0m) | ($31.0m) | ($20.0m) | — | $63.0m | ($48.0m) | ($17.0m) | $11.0m | ($1.0m) | |
| Increase in accounts receivable | ($433.0m) | ($1.1b) | ($1.2b) | ($289.0m) | — | $774.0m | ($2.4b) | ($1.3b) | ($406.0m) | ($1.8b) | |
| Increase in inventories | ($449.0m) | ($249.0m) | ($644.0m) | ($277.0m) | — | ($265.0m) | ($1.2b) | ($2.5b) | ($1.1b) | ($1.4b) | |
| Increase in accounts payable and accrued liabilities | ($3.0m) | $656.0m | $4.0b | $4.1b | — | $5.1b | $2.4b | $1.1b | $1.6b | $2.4b | |
| (Increase)/Decrease in other current and non-current assets | $65.0m | $18.0m | ($275.0m) | ($1.1b) | — | ($3.7b) | ($2.0b) | $687.0m | $1.7b | ($6.2b) | |
| (Decrease)/Increase in other current and non-current liabilities | $2.2b | ($1.1b) | ($1.8b) | $1.4b | — | $744.0m | ($1.1b) | ($2.0b) | $33.0m | ($5.7b) | |
| Proceeds from the disposal of assets/businesses, net | $3.5b | $1.3b | $3.2b | $3.3b | — | $305.0m | $711.0m | $543.0m | $675.0m | $720.0m | |
| Acquisitions, net of cash acquired | ($954.0m) | ($4.5b) | ($899.0m) | ($5.8b) | — | ($7.3b) | ($60.0m) | ($17.7b) | ($15.1b) | ($17.5b) | |
| Acquired in-process research and development/related milestones (Note 18) | — | — | — | — | — | — | — | ($470.0m) | ($1.8b) | ($385.0m) | |
| Credit support agreements activity, net | — | — | $25.0m | $100.0m | — | ($333.0m) | $281.0m | ($28.0m) | $272.0m | ($226.0m) | |
| Other (including capitalized licenses and milestones) | ($57.0m) | ($15.0m) | ($148.0m) | $575.0m | — | ($294.0m) | $114.0m | $93.0m | ($38.0m) | ($34.0m) | |
| Proceeds from the exercise of stock options/employee withholding tax on stock awards, net | $1.3b | $1.2b | $949.0m | $954.0m | — | $1.1b | $1.0b | $1.3b | $838.0m | $3.4b | |
| Settlement of convertible debt acquired from Shockwave | — | — | — | — | — | — | — | $0 | ($970.0m) | $0 | |
| Proceeds from Kenvue initial public offering | — | — | — | — | — | — | — | $4.2b | $0 | $0 | |
| Cash transferred to Kenvue at separation | — | — | — | — | — | — | — | ($1.1b) | $0 | $0 | |
| Interest | $617.0m | $730.0m | $1.0b | $995.0m | — | $904.0m | $990.0m | $982.0m | $2.0b | $2.0b | |
| Interest, net of amount capitalized | $515.0m | $628.0m | $963.0m | $925.0m | — | $841.0m | $941.0m | $933.0m | $1.9b | $1.9b | |
| Treasury stock issued for employee compensation and stock option plans, net of cash proceeds/ employee withholding tax on stock awards | $1.2b | $2.0b | $2.1b | $1.7b | — | $1.9b | $1.8b | $2.1b | $1.6b | $2.6b | |
| Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax | — | — | — | — | — | — | — | $21.0b | $0 | $0 | |
| Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax | — | ($359.0m) | $192.0m | ($7.0m) | $53.0m | — | — | — | — | — | |
| Net Cash Provided by (Used in) Operating Activities | $19.3b | $21.1b | $22.2b | $23.4b | $23.5b | $23.4b | $23.4b | $22.8b | $24.3b | $24.5b | |
| Cash flows from investing activities: | |||||||||||
| Payments to Acquire Property, Plant, and Equipment | ($3.5b) | $3.3b | $3.7b | $3.5b | $3.3b | $3.7b | ($3.7b) | $4.5b | $4.4b | $4.8b | |
| Payments to Acquire Businesses, Net of Cash Acquired | — | $35.2b | $899.0m | $5.8b | $7.3b | $60.0m | — | $0 | $15.1b | $17.5b | |
| Payments to Acquire Investments | — | $6.2b | $5.6b | $3.9b | $21.1b | $30.4b | — | $10.9b | $1.7b | $920.0m | |
| Purchases of investments | ($40.8b) | ($34.0b) | ($5.6b) | ($3.9b) | — | ($21.1b) | ($30.4b) | ($32.4b) | ($1.7b) | ($920.0m) | |
| Sales of investments | $34.1b | $35.8b | $4.3b | $3.4b | — | $12.1b | $25.0b | $41.6b | $2.5b | $1.7b | |
| Payments for (Proceeds from) Other Investing Activities | — | $234.0m | $464.0m | ($44.0m) | $521.0m | $508.0m | — | ($12.0m) | $174.0m | $162.0m | |
| Net cash (used by)/from investing activities | ($7.7b) | ($4.8b) | ($3.2b) | ($6.2b) | — | ($20.8b) | ($8.7b) | ($12.4b) | ($18.6b) | ($23.6b) | |
| Net Cash Provided by (Used in) Investing Activities | — | ($14.9b) | ($3.2b) | ($6.2b) | ($20.8b) | ($8.7b) | — | $878.0m | ($18.6b) | ($23.6b) | |
| Cash flows from financing activities: | |||||||||||
| Proceeds from Issuance of Long-term Debt | — | $9.0b | $5.0m | $3.0m | $7.4b | $5.0m | — | $0 | $6.7b | $9.1b | |
| Proceeds from short-term debt | $2.4b | $111.0m | $80.0m | $39.0m | — | $3.4b | $2.0b | $16.1b | $15.3b | $14.6b | |
| Proceeds from long-term debt, net of issuance costs | $75.0m | $12.0b | $5.0m | $3.0m | — | $7.4b | $5.0m | $2.0m | $6.7b | $9.1b | |
| Proceeds of short and long-term debt, net of issuance cost, related to the debt that transferred to Kenvue at separation | — | — | — | — | — | — | — | $8.0b | $0 | $0 | |
| Repayments of Long-term Debt | — | $1.8b | $1.6b | $2.8b | $1.1b | $1.8b | — | $1.6b | $1.5b | $1.8b | |
| Repayment of short-term debt | ($1.0b) | ($2.0b) | ($2.5b) | ($100.0m) | — | ($2.7b) | ($1.2b) | ($6.5b) | ($9.5b) | ($12.3b) | |
| Repayment of long-term debt | ($68.0m) | ($2.2b) | ($1.6b) | ($2.8b) | — | ($1.1b) | ($1.8b) | ($2.1b) | ($1.5b) | ($1.8b) | |
| Payments for Repurchase of Common Stock | — | $6.4b | $5.9b | $6.7b | $3.2b | $3.5b | — | $5.1b | $2.4b | $6.0b | |
| Repurchase of common stock | ($5.3b) | ($9.0b) | ($5.9b) | ($6.7b) | — | ($3.2b) | ($3.5b) | ($6.0b) | ($2.4b) | ($6.0b) | |
| Dividends to shareholders | ($8.2b) | ($8.6b) | ($9.5b) | ($9.9b) | — | ($10.5b) | ($11.0b) | ($11.7b) | ($11.8b) | ($12.4b) | |
| Proceeds from (Payments for) Other Financing Activities | — | ($188.0m) | ($148.0m) | $575.0m | ($294.0m) | $114.0m | — | ($269.0m) | ($38.0m) | ($34.0m) | |
| Net cash used by financing activities | ($10.8b) | ($8.6b) | ($18.5b) | ($18.0b) | — | ($6.1b) | ($14.0b) | ($8.9b) | ($3.1b) | ($5.5b) | |
| Net Cash Provided by (Used in) Financing Activities | — | ($7.7b) | ($18.5b) | ($18.0b) | ($6.1b) | ($14.0b) | — | ($15.8b) | ($3.1b) | ($5.5b) | |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | — | ($9.0m) | $89.0m | ($178.0m) | — | ($112.0m) | ($289.0m) | $201.0m | |
| Effect of exchange rate changes on cash and cash equivalents | ($1.5b) | ($215.0m) | ($241.0m) | ($9.0m) | — | $89.0m | ($178.0m) | ($312.0m) | ($289.0m) | $201.0m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | — | — | ($802.0m) | ($3.3b) | $502.0m | — | $7.7b | $2.2b | ($4.4b) | |
| (Decrease)/Increase in cash and cash equivalents | ($791.0m) | ($1.1b) | $283.0m | ($802.0m) | — | ($3.3b) | $502.0m | ($360.0m) | $2.2b | ($4.4b) | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | — | $17.3b | $14.0b | $14.5b | — | $21.9b | $24.1b | $19.7b | |
| Cash, Cash Equivalents, and Short-term Investments | — | — | — | — | — | — | — | — | — | — | |
| Cash and cash equivalents, beginning of year | $14.5b | $13.7b | $17.8b | $17.3b | — | $14.0b | $14.5b | $14.1b | $24.1b | $19.7b | |
| Supplemental disclosure of cash flow information: | |||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | — | $866.0m | $963.0m | $925.0m | $841.0m | $941.0m | — | $1.8b | $1.9b | $1.9b | |
| Income Taxes Paid, Net | — | — | — | — | — | — | — | — | — | $6.5b |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.